NewsBenzinga日曜日に発表されたNovo、ObesityWeekでCagriSemaのREDEFINE 1事後解析2件を発表:早期反応者で平均25.4%の体重減少、身体機能の有意な改善は73.1%対プラセボ49.1% 日曜日に発表されたNovo、ObesityWeekでCagriSemaのREDEFINE 1事後解析2件を発表:早期反応者で平均25.4%の体重減少、身体機能の有意な改善は73.1%対プラセボ49.1% Benzinga 2026.11.16 06:38 (GMT+0) Open on Benzinga Other news Nvidia’s $105 Billion OpenAI Bet Has a 20-Year Catch Freedom Broker Upgrades Espey Manufacturing to Buy, Maintains Price Target to $70 QUICK SPARK: Chip Stocks Eye Worst Two-Month Drop Since 2008 Carlyle, Clearlake Bet Big On Sports — And PE Deals Are Surging Target's $301 Million Tariff Windfall 'Flattered' Earnings, Analyst Says Freedom Broker Maintains Buy on SKYX Platforms, Lowers Price Target to $2